Pros | 3Y returns in the top 25% of the category. Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | 5Y returns in the bottom 25% of the category. 3Y returns in the bottom 25% of the category. |
INDMoney rank | 7/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 13 Years 3 Months | 13 Years 3 Months | ||
Fund AUM | ₹1102 Cr | ₹8265 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 1.28% | 0.92% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 45 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 99.4% | 97.37% | ||
Debt % | - | - | ||
P/E | 37.22 | 35.17 | ||
P/B | 5.48 | 5.57 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -5.6% | -5.23% | ||
3-Month Return | -6.71% | -5.04% | ||
6-Month Return | -6.62% | -5.7% | ||
1-Year Return | 0.97% | 1.91% | ||
3-Year Return | 24.53% | 22.06% | ||
5-Year Return | 15.68% | 15.45% |
Sharpe | 1.06 | 0.97 | ||
Alpha | 1.8 | 0.33 | ||
Beta | 0.94 | 0.9 | ||
Standard Deviation | 15.92 | 15.32 | ||
Information Ratio | 0.36 | -0.32 |
Description | UTI Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Kamal Gada | Sailesh Raj Bhan, Lokesh Maru, Divya Sharma, Kinjal Desai |